XML 29 R18.htm IDEA: XBRL DOCUMENT v3.22.0.1
Derivative Financial Instruments (Notes)
3 Months Ended
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative financial instruments and hedging DERIVATIVE FINANCIAL INSTRUMENTS
In the ordinary course of business, the Company is exposed to commodity price risks relating to the acquisition of raw materials and supplies, interest rate risks relating to floating rate debt and foreign currency exchange rate risks. The Company utilizes swaps to manage certain of these exposures by hedging when it is practical to do so. The Company does not hold or issue financial instruments for speculative or trading purposes.
At both December 31, 2021 and September 30, 2021, the Company had pay-fixed, receive-variable interest rate swaps with a notional amount of $350.0. The interest rate swaps mature in December 2022 and require monthly settlements, which began on January 31, 2020, and are used to hedge forecasted interest payments on the Company’s variable rate debt (see Note 14). On April 1, 2020, the Company changed the designation of the interest rate swaps from cash flow hedges to non-designated hedging instruments as the swaps were no longer effective (as defined by GAAP). In connection with the new designation, the Company started reclassifying losses previously recorded in accumulated OCI to “Interest expense, net” in the Condensed Consolidated Statements of Operations on a straight-line basis over the term of the related debt.
At December 31, 2021, accumulated OCI, including amounts reported as NCI, included a $6.6 net hedging loss before taxes ($6.2 after taxes). At September 30, 2021, accumulated OCI, including amounts reported as NCI, included a $7.1 net hedging loss before taxes ($6.7 after taxes). Approximately $2.3 of the net hedging loss reported in accumulated OCI at December 31, 2021 is expected to be reclassified into earnings within the next 12 months.
The following table presents the balance sheet location and fair value of the Company’s derivative instruments on a gross basis. The Company does not offset derivative assets and liabilities within the Condensed Consolidated Balance Sheets.
December 31,
2021
September 30,
2021
Other current liabilities$3.6 $4.7 
Other liabilities— 1.1 
Total liabilities$3.6 $5.8 
The following table presents the components of the Company’s net hedging loss on interest rate swaps which were included in “Interest expense, net” in the Condensed Consolidated Statements of Operations and the net cash settlements paid on interest rate swaps.
Three Months Ended
December 31,
20212020
Mark-to-market adjustments$(0.9)$— 
Net loss amortized from accumulated OCI0.5 0.5 
Total net hedging (gain) loss$(0.4)$0.5 
Cash settlements paid$(1.3)$(1.2)